Additionally, since HMGB1 acting on RAGE and TLR4 represents key pathways for the formation of cigarette-smoke-induced COPD inflammation [162,163], increased pulmonary expression of HMGB1 in COPD is a further potential target for inhaled heparin therapy. The gene discussed is HMGB1; the disease is chronic obstructive pulmonary disease.